GUTS ▲ +12.7% - Fractyl Health, Inc.
$GUTS - Fractyl Health's Revita Meets Six-Month Co-Primary Endpoint in Ongoing REMAIN-1 Pivotal Study, With Highly Statistically Significant Reduction in Weight Regain After GLP-1 Discontinuation
16-OCT-2026 07:00 AM ET
Share this post
More filings for $GUTS
View full $GUTS filing history →💬 Comments
Loading comments…
Leave a comment
